Sanofi India Q1 net profit down 8 percent to Rs 85.4 crores
New Delhi: Drug firm Sanofi India on Tuesday reported 8 per cent decline in its net profit to Rs 85.4 crore for the first quarter ended March 31, 2020.
The company had posted a net profit of Rs 92.9 crore for the same period previous fiscal, Sanofi India said in a regulatory filing.
The company follows a January-December financial year.
Revenue from operations of the company stood at Rs 784.5 crore for the quarter under consideration. It was Rs 717.3 crore for the same period a year ago, it added.
Shares of Sanofi India closed at Rs 7,469.20 per scrip on BSE, down 0.09 per cent from its previous close.
Read also: Sanofi gets USFDA priority review for sutimlimab for Hemolysis
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.